540743 Fair Value & Analysis
Consumer Non-Cyclicals · IN · Market cap ₹88.4B
Fair value as of: Aug 2, 2026
From 24 valuation models · updated 8 days ago
Share price +3.0% over the past month.
A solid business, screening 11% undervalued on our models.
What matters now
- Our model range runs from ₹444.13 (bear) to ₹781.31 (bull), base ₹616.73. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 68/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 2, 2026.
How to read this chart
60‑month range ₹368.10 – ₹831.00 · fair‑value band ₹444.13 – ₹781.31 · the ₹556.65 price screens below the ₹616.73 fair value. Dashed = 300-day average. As of Aug 2, 2026.
Analysis
540743 (540743) currently trades at ₹556.65, while our model-based Fair Value estimate is ₹616.73, implying the stock looks roughly 10.8% undervalued today. The Quality Score stands at 68/100 (solid quality), in the Consumer Non-Cyclicals sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Net debt stands at ₹11.7B. The stock trades on a trailing P/E of 28.9. Fundamentals as of Aug 2, 2026
Our scenario range runs from ₹444.13 (bear case) to ₹781.31 (bull case); at ₹556.65, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 12% above its 52-week low. For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at 7% fair-value upside, at 11%, 540743 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (₹794.11) versus Asset-Based (₹85.71). Highest evidence: Growth DCF (80).
Key figures & financial health
Figures from reported company fundamentals · as of Aug 2, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 65 · Market factors (momentum, volatility) 37
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
540743 reported revenue of ₹102B in FY2025 versus ₹83.1B in FY2021, a compound +5.3%/yr. Reported net income was ₹4.7B in FY2025, compounding +4.1%/yr from FY2021.
Watch 540743: get an alert when its fair value changes →
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate (as of Aug 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| FB FB | 49.00 PHP | 49.03 PHP | +0% |
| URC URC | 61.20 PHP | 47.86 PHP | -22% |
| CNPF CNPF | 32.50 PHP | 64.84 PHP | +100% |
| DNL DNL | 3.64 PHP | 3.43 PHP | -6% |
| RFM RFM | 5.41 PHP | 8.87 PHP | +64% |
| AXLM AXLM | 2.70 PHP | 2.89 PHP | +7% |
| EASY BIO,Inc. 353810 | 6,120 KRW | 17,633 KRW | +188% |
| Helixmith Co 084990 | 3,315 KRW | 823.10 KRW | -75% |
| LFM LFM | 26.60 PHP | 7.12 PHP | -73% |
| MSC Co 009780 | 6,020 KRW | 22,224 KRW | +269% |
Compare 540743 with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is 540743 overvalued or undervalued?
What is the fair value of 540743?
What is the quality score of 540743?
What is the net profit margin of 540743?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track 540743 and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.